Currently viewing the tag: "biologics"

Biosimilar Bills Foment Heated Debate

On July 23, 2009 By

Most people agree that a generic biologics pathway for the U.S. Food and Drug Administration (FDA) approval of these drugs would be a boon to consumers, but different parties seem to be at odds on the exact exclusivity period that the pharmaceutical companies should be given from their generic drug competitors.

These generic biologics […]

Continue Reading